ResearcherShanxi Medical UniversityActive in the last 2 years

Jinbin Jia

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5109751343. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 9

Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 3

SIGLEC12 Predicts Prognosis and Chemotherapeutic Vulnerability in Patients with Pancreatic Cancer. Last author DOI 10.1245/s10434-026-20077-6 ↗
Tumor-associated macrophages (TAMs): Constructing an immunosuppressive microenvironment bridge for pancreatic ductal adenocarcinoma (PDAC). Last author DOI 10.1016/j.cpt.2024.07.004 ↗
Abrogation of KLF5 sensitizes BRCA1-proficient pancreatic cancer to PARP inhibition. Co-author DOI 10.3724/abbs.2023288 ↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wenquan Wang · 2 shared papers, 2024–2025 · strength 0.56
- Paper Tumor-associated macrophages (TAMs): Constructing an immunosuppressive microenvironment bridge for pancreatic ductal ad… DOI 10.1016/j.cpt.2024.07.004 ↗
- Paper Abrogation of KLF5 sensitizes BRCA1-proficient pancreatic cancer to PARP inhibition. DOI 10.3724/abbs.2023288 ↗
Yanfei An · 1 shared paper, 2026 · strength 0.50
- Paper SIGLEC12 Predicts Prognosis and Chemotherapeutic Vulnerability in Patients with Pancreatic Cancer. DOI 10.1245/s10434-026-20077-6 ↗
Jianang Li · 1 shared paper, 2025 · strength 0.33
- Paper Tumor-associated macrophages (TAMs): Constructing an immunosuppressive microenvironment bridge for pancreatic ductal ad… DOI 10.1016/j.cpt.2024.07.004 ↗
Liang Liu · 1 shared paper, 2025 · strength 0.33
- Paper Tumor-associated macrophages (TAMs): Constructing an immunosuppressive microenvironment bridge for pancreatic ductal ad… DOI 10.1016/j.cpt.2024.07.004 ↗
Runjie Liu · 1 shared paper, 2025 · strength 0.33
- Paper Tumor-associated macrophages (TAMs): Constructing an immunosuppressive microenvironment bridge for pancreatic ductal ad… DOI 10.1016/j.cpt.2024.07.004 ↗
Liang Liu · 1 shared paper, 2024 · strength 0.23
- Paper Abrogation of KLF5 sensitizes BRCA1-proficient pancreatic cancer to PARP inhibition. DOI 10.3724/abbs.2023288 ↗
Zheng Zhang · 1 shared paper, 2024 · strength 0.23
- Paper Abrogation of KLF5 sensitizes BRCA1-proficient pancreatic cancer to PARP inhibition. DOI 10.3724/abbs.2023288 ↗
Zijin Xu · 1 shared paper, 2024 · strength 0.23
- Paper Abrogation of KLF5 sensitizes BRCA1-proficient pancreatic cancer to PARP inhibition. DOI 10.3724/abbs.2023288 ↗
Yun Jin · 1 shared paper, 2024 · strength 0.23
- Paper Abrogation of KLF5 sensitizes BRCA1-proficient pancreatic cancer to PARP inhibition. DOI 10.3724/abbs.2023288 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.